124
M. Mazzei et al. / Il Farmaco 58 (2003) 121ꢀ127
/
rated under reduced pressure leaving a solid. The solid
was crystallized from ethyl acetate yielding 5, m.p.: 190ꢀ
191 8C; 74.4% yield.
1H NMR (CDCl3): d 1.28ꢀ
piperidine), 2.78-3.16 (m, 8H, CH2 a-piperidine), 3.44 (s,
2H, CH2 bridge), 3.66 (s, 6H, OCH3-orto), 3.86 (s, 6H,
OCH3-para) 6.32-6.75 (m, 4H, H arom), 7.35 (d, 2H, H
arom). IR (KBr) cmꢁ1: 1635, 1600, 1580. Anal.
C33H40N4O6 (C, H, N).
3.8. 4,4?-Methylenbis[3-(1-piperidinyl)-5-(2-[2-N,N-
diethylaminoethoxy]-4-methoxy-phenyl)isoxazole] (9)
/
/
1.75 (m, 12H, CH2 b, g-
To 1.90 g (3.4 mmol) of methylene-bis isoxazole 4
dissolved in 19 ml of DMF, 1.75 g (10.2 mmol) of 2-
(diethylamino)ethyl chloride hydrochloride and 1.87 g
of anhydrous potassium carbonate were added and the
mixture was heated at 120 8C for 7 h. After cooling, 30
ml of water were added obtaining a precipitate that was
crystallized from diethyl ether/light petroleum ether.
The derivative 9 was obtained; m.p.: 82ꢀ
yield.
1H NMR (CDCl3): d 0.93 (t, 12H, NCH2CH3), 1.31ꢀ
1.70 (m, 12H, CH2 b, g-piperidine), 2.30ꢀ2.72 (m, 12H,
NCH2), 2.80ꢀ3.15 (m, 8H, CH2 a-piperidine), 3.30ꢀ3.96
6.75 (m, 4H,
/
83 8C: 21.7%
3.5. 4,4?-Methylenbis[3-(1-piperidinyl)-5-(2-ethoxy-4-
methoxyphenyl)isoxazole] (6)
/
/
To 0.28 g (0.5 mmol) of methylene-bis isoxazole 4
dissolved in 3 ml of NaOH 1 N, 0.25 g of diethylsulfate
were added and the mixture were heated for 3 h at
90 8C. With the same procedure as above the derivative
/
/
(m, 12H, CH2 bridge, OCH2, OCH3), 6.34ꢀ
/
H arom), 7.19 (d, 2H, H arom). IR (KBr) cmꢁ1: 1638,
1605, 1515. Anal. C43H62N6O6 (C, H, N).
6 was obtained; m.p.: 192ꢀ
1H NMR (CDCl3): d 1.05ꢀ
1.37ꢀ1.72 (m, 12H, CH2 b, g-piperidine), 2.82ꢀ
8H, CH2 a-piperidine), 3.38ꢀ3.65 (q, 4H, CH2CH3),
/
193 8C; 85.3% yield.
1.34 (t, 6H, CH2CH3),
3.20 (m,
/
/
/
4. Biology
/
3.76 (s, 2H, CH2 bridge), 3.86 (s, 6H, OCH3), 6.48ꢀ6.72
/
(m, 4H, H arom), 7.38 (d, 2H, H arom). IR (KBr) cmꢁ1
1638, 1605, 1577. Anal. C35H44N4O6 (C, H, N).
:
4.1. Isolation of neutrophils
Freshly collected heparinized human blood (100 ml)
from healthy donors was treated with 1.6% dextran
3.6. 4,4?-Methylenbis[3-(1-piperidinyl)-5-(2-acetoxy-4-
methoxyphenyl)isoxazole] (7)
(final concentration) and left at 25ꢀ28 8C to sedimentate
/
for 1 h. The supernatants (40 ml) were collected and
layered onto 10 ml of 6% Ficoll 400 solution containing
A 0.28 g quantity (0.5 mmol) of methylene-bis
isoxazole 4 was dissolved in 5 ml of acetic anhydride
and heated for 1.5 h at 95 8C. At the end, after cooling,
the solution was poured onto crushed ice and the
0.17% (v/v) Urovison and centrifuged at 800ꢄg for 20
/
min. The pellets containing mostly neutrophils and
contaminating red cells were resuspended in 10 ml of
hypotonic 0.2% NaCl. After 30 s, 10 ml of hypertonic
1.6% NaCl were added to normalize the osmotic
pressure. This treatment lyses all contaminating red
cells. The white cells were recovered and washed three
times with 0.01 M sodium phosphate (pH 7.4), 5 mM
KCl, 0.12 M NaCl, 24 mM NaHCO3, 5 mM glucose.
Prior to use, the cells were maintained in an ice bath in
mixture was stirred for 1ꢀ
solid was filtered off and crystallized from ethyl acetate
yielding 7; m.p.: 237ꢀ238 8C; 71.1% yield.
1H NMR (CDCl3): d 1.49ꢀ
1.90 (m, 12H, CH2 b, g-
piperidine), 2.37 (s, 6H, COCH3), 3.12ꢀ3.50 (m, 8H,
CH2 a-piperidine), 3.85 (s, 8H, CH2 bridge, OCH3),
/2 h obtaining a solid. The
/
/
/
the same medium at a concentration of 15ꢀ
/
20ꢄ
106 cells
/
6.56ꢀ7.10 (m, 4H, H arom), 7.80 (d, 2H, H arom). IR
/
(KBr) cmꢁ1: 1766, 1618, 1572. Anal. C35H40N4O8 (C,
H, N).
per ml. The cell population obtained consisted of more
than 96% neutrophils, as evaluated by microscopic
examination. The few remaining cells were eosinophils
and monocytes. Cell viability, evaluated by Trypan Blue
dye exclusion, resulted to be more than 97%.
3.7. 4,4?-Methylenbis[3-(1-piperidinyl)-5-(2-propyloxy-
4-methoxyphenyl)isoxazole] (8)
A 0.28 g quantity (0.5 mmol) of methylene-bis-
isoxazole 4 was dissolved in 5 ml of propionic anhy-
dride. With the same procedure as above the derivative 8
4.2. Activation of neutrophils and assay of superoxide
anion (O2ꢁ)
was obtained: m.p.: 232ꢀ
1H NMR (CDCl3): d 1.04 (t, 6H, CH2CH3), 1.42ꢀ
1.73 (m, 12H, CH2 b, g-piperidine), 2.25 (q, 4H,
COCH2), 2.95ꢀ3.25 (m, 8H, CH2 a-piperidine), 3.84
/
233 8C; 71.5% yield.
Cells (106) were diluted in 1 ml of 10 mM HEPES, pH
7.4, containing 0.15 M NaCl, 5.0 mM glucose, 1.0 mM
Ca2ꢂ and 0.625 mg mlꢁ1 of cytochrome C (Fe3ꢂ) and
incubated at 37 8C for 2 min. PMA (100 ng) or f-MLP,
(0.1 mM final concentration) were then added. Super-
oxide production was evaluated by measuring the
superoxide dismutase-inhibitable reduction of ferricyto-
/
/
(s, 8H, CH2 bridge, OCH3), 6.67ꢀ6.98 (m, 4H, H arom),
/
7.69 (d, 2H, H arom). IR (KBr) cmꢁ1: 1768, 1620, 1515.
Anal. C37H44N4O8 (C, H, N).